Acadian Asset Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $726K | Buy |
91,075
+9,905
| +12% | +$79K | ﹤0.01% | 1060 |
|
2025
Q1 | $790K | Sell |
81,170
-26,691
| -25% | -$260K | ﹤0.01% | 985 |
|
2024
Q4 | $1.36M | Buy |
107,861
+2,591
| +2% | +$32.7K | ﹤0.01% | 865 |
|
2024
Q3 | $1.69M | Buy |
105,270
+46,872
| +80% | +$753K | 0.01% | 791 |
|
2024
Q2 | $1.42M | Buy |
58,398
+57,035
| +4,185% | +$1.39M | ﹤0.01% | 882 |
|
2024
Q1 | $97K | Buy |
+1,363
| New | +$97K | ﹤0.01% | 1293 |
|